Anti-Phagocyte Antibodies and Infection

References

• Goldschmeding R., van der Schoot C. E., ten Bokkel Huinink D., Hack C. E., van den Ende M. E., Kallenberg C. G.M., et al. Wegener's Granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest 1989; 84: 1577–1587
   PubMed Web of Science ®Google Scholar
• Calafat J., Goldschmeding R., Ringeling P. L., Janssen H., van der Schoot C. E. In situlocalisation by double-labelling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood 1990; 15: 242–250
   Google Scholar
• Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N. Engl. J. Med. 1988; 318: 1651–1657
   PubMed Web of Science ®Google Scholar
• Lee S. S., Lawton W. M., Chan C. E. Antilactoferrin antibody in systemic lupus erythematosous. Br. J. Rheumatol 1992; 31: 669–673
   PubMedGoogle Scholar
• Halbwechs-Mecarelli L., Nusbaum P., Nöel L. H., Reumaux D., Erlinger S., Grünfeld J. P., et al. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against Cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol 1992; 90: 79–84
   PubMed Web of Science ®Google Scholar
• Nässberger L., Johansson A. C., Björck S., Sjöholm A. G. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. J. Int. Med. 1991; 229: 261–265
   PubMed Web of Science ®Google Scholar
• Schmitt W. H., Csernok E., Flesch B. K., Hauschild S., Gross W. L. Autoantibodies directed against lysozyme: a new target for anti-neutrophil cytoplasmic antibodies. Adv. Exp. Med. Biol 1993; 336: 267–273
   PubMedGoogle Scholar
• Moodie F. D.L., Leaker B., Cambridge G., Totty N. F., Segal A. W. Alpha-enolase: A novel autoantigen in ANCA positive vasculitis. Kid. Int. 1993; 43: 675–681
   PubMed Web of Science ®Google Scholar
• Zhao M. H., Jones S. J., Lockwood C M. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in vasculitis. Clin. Exp. Immunol 1995; 9: 49–56
   Google Scholar
• Kain R., Matsui K., Exner M., Binder S., Schaffner G., Sommer E., et al. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J. Exp. Med. 1995; 181: 585–597
   PubMed Web of Science ®Google Scholar
• Zhao M. H., Lockwood C M. Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis. Clin. Exp. Immunol 1996; 103: 397–402
   PubMed Web of Science ®Google Scholar
• Van der Woulde F. J., Rasmussen N., Lobattos S., Wiik A., Permin H., van Es L. A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker for disease activity in Wegener's granulomatosis. Lancet 1985; 2: 425–429
   Google Scholar
• Kallenberg C. G.M., Mulder A. H.L., Cohen Tervaert J.W. Anti-neutrophil cytoplasmic antibodies: a still growing class of autoantibodies in inflammatory disorders. Am. J. Med. 1992; 93: 675–682
   PubMed Web of Science ®Google Scholar
• Forde A. M., Feighery C., Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin. Immunol. Immunopathol 1996; 81: 88–95
   PubMedGoogle Scholar
• Roos D., Dolman K. M. Neutrophil involvement in inflammatory tissue damage. Netherlands J. Med. 1990; 36: 89–94
   PubMed Web of Science ®Google Scholar
• Ballieux B. E., Hiemstra P. S., Klar-Mohamad N., Hagen E. C, van-Es L. A., van der Woulde F. J., et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur. J. Immunol 1994; 24: 3211–3215
   PubMed Web of Science ®Google Scholar
• Schwartz R. S. Mechanisims of autoimmunity. Clinical Immunology Principles and Practice, R. R. Rich. Mosby, St. Louis 1996; Vol. 2: 1053–1061
   Google Scholar
• Pharmacia. Coupling gels for ligand immobilisation. Affinity Chromatography, Principles and Methods. Pharmacia, Sweden 1986; 11–34
   Google Scholar
• Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A. distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J. Allergy Clin. Immunol 1990; 8: 202–210
   Google Scholar
• Efthimiou J., Spickett G., Lane D., Thompson A. Anti-neutrophil cytoplasmic antibodies, cystic fibrosis and infection [letter]. Lancet 1991; 337: 1037–1038
   PubMed Web of Science ®Google Scholar
• Schmitt W. H., Csernok E., Gross W. L. ANCA and infection [letter]. Lancet 1991; 337: 1416–1417
   PubMed Web of Science ®Google Scholar
• Gallicchio M. C., Savige J. A. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin. Exp. Immunol 1990; 84: 232–237
   Web of Science ®Google Scholar
• Finnegan M. J., Hinchcliffe D., Russell-Jones D., Neill S., Sheffield E., Jayne D., et al. Vasculitis complicating cystic fibrosis. Q. J. Med. 1989; 72: 609–621
   PubMedGoogle Scholar
• Pudifin D. J., Duursma J., Gathiram V., Jackson T. F.H.G. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin. Exp. Immunol 1994; 97: 48–51
   PubMed Web of Science ®Google Scholar
• Zhao M. H., Jayne D. R.W., Ardiles L., Culley F., Hodson M. E., Lockwood C M. Autoantibodies against bactericidal/permeability-increasing protein (BPI) in cystic fibrosis. Q. J. Med. 1996; 89: 259–265
   Google Scholar
• Galperin C., Shoenfeld Y., Gilburd B., Esterre P., Meroni P. L., Del-Papa N., et al. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin. Exp. Rheumatol 1996; 14: 479–483
   PubMed Web of Science ®Google Scholar
• Wenisch C., Wenish H., Bankl H. C., Exner M., Graninger W., Looareesuwan S., et al. Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol 1996; 3: 131–134
   Google Scholar
• Enzymes as autoantigens [editorial]. Lancet 1992; 339: 779–780
   PubMed Web of Science ®Google Scholar
• Van der Wiel B. A., Dolman K. M., Van der Meer-Gerritsen C. H., Hack C. E., Von dem Borne A. E.G.Kr., Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin. Exp. Immunol 1992; 90: 409–414
   PubMed Web of Science ®Google Scholar
• Daouk G. H., Palsson R., Arnaout M. A. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kid. Int. 1995; 47: 1528–1536
   PubMed Web of Science ®Google Scholar